Casma: Casma Therapeutics to Present at the UBS Virtual Biotechnology Private Company Symposium

(marketscreener.com) CAMBRIDGE, Mass., Sept. 15, 2021 -- Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to design powerful new medicines, today announced that Keith Dionne, Ph.D., Chief Executive Officer of Casma, will participate in the upcoming virtual UBS Virtual Biotechnology Private Company Symposium being held on...https://www.marketscreener.com/news/latest/Casma-Therapeutics-to-Present-at-the-UBS-Virtual-Biotechnology-Private-Company-Symposium--36436428/?utm_medium=RSS&utm_content=20210915